Page 113 - 《中国药房》2024年10期

tumour response to docetaxel-based neo-adjuvant chemo‐ paclitaxel chemotherapy[J]. Mod Sci Instrum，2022，39
therapy in locally advanced breast cancer patients of （2）：134-138.
South India[J]. J Clin Pharm Ther，2019，44（2）：188-196. [15] TANABE Y，SHIMIZU C，HAMADA A，et al. Paclitaxel-
[ 5 ] JI M H，TANG J H，ZHAO J H，et al. Polymorphisms in induced sensory peripheral neuropathy is associated with
genes involved in drug detoxification and clinical out‐ an ABCB1 single nucleotide polymorphism and older age
comes of anthracycline-based neoadjuvant chemotherapy in Japanese[J]. Cancer Chemother Pharmacol，2017，79
in Chinese Han breast cancer patients[J]. Cancer Biol （6）：1179-1186.
Ther，2012，13（5）：264-271. [16] TSAI S M，LIN C Y，WU S H，et al. Side effects after
[ 6 ] CHOI J R，KIM J O，KANG D R，et al. Genetic variations docetaxel treatment in Taiwanese breast cancer patients
of drug transporters can influence on drug response in with CYP3A4，CYP3A5，and ABCB1 gene polymor‐
patients treated with docetaxel chemotherapy[J]. Cancer phisms[J]. Clin Chim Acta，2009，404（2）：160-165.
Res Treat，2015，47（3）：509-517. [17] ECKHOFF L，FEDDERSEN S，KNOOP A S，et al.
[ 7 ] TULSYAN S，MITTAL R D，MITTAL B. The effect of Docetaxel-induced neuropathy：a pharmacogenetic case-
ABCB1 polymorphisms on the outcome of breast cancer control study of 150 women with early-stage breast cancer
treatment[J]. Pharmgenomics Pers Med，2016，9：47-58. [J]. Acta Oncol，2015，54（4）：530-537.
[ 8 ] ANGELINI S，BOTTICELLI A，ONESTI C E，et al. Phar‐ [18] ABDELFATTAH N M，SOLAYMAN M H，ELNAHASS
macogenetic approach to toxicity in breast cancer patients Y，et al. ABCB1 single nucleotide polymorphism geno‐
treated with taxanes[J]. Anticancer Res，2017，37（5）： types as predictors of paclitaxel-induced peripheral neu‐
2633-2639. ropathy in breast cancer[J]. Genet Test Mol Biomarkers，
[ 9 ] KIM H J，IM S A，KEAM B，et al. ABCB1 polymorphism 2021，25（7）：471-477.
as prognostic factor in breast cancer patients treated with [19] KIM K P，AHN J H，KIM S B，et al. Prospective evaluation
docetaxel and doxorubicin neoadjuvant chemotherapy[J]. of the drug-metabolizing enzyme polymorphisms and
Cancer Sci，2015，106（1）：86-93. toxicity profile of docetaxel in Korean patients with operable
[10] STANG A. Critical evaluation of the Newcastle-Ottawa lymph node-positive breast cancer receiving adjuvant
scale for the assessment of the quality of nonrandomized chemotherapy[J]. Cancer Chemother Pharmacol，2012，69
studies in meta-analyses[J]. Eur J Epidemiol，2010，25 （5）：1221-1227.
（9）：603-605. [20] DEMURTAS S，VERDE N L，ROTA S，et al. Single
[11] CHANG H，RHA S Y，JEUNG H C，et al. Association of nucleotide polymorphisms to predict taxanes toxicities
the ABCB1 gene polymorphisms 2677G＞T/A and and effectiveness in cancer patients[J]. Pharmacogeno-
3435C＞T with clinical outcomes of paclitaxel mono‐ mics J，2021，21（4）：491-497.
therapy in metastatic breast cancer patients[J]. Ann Oncol， [21] JABIR R S，NAIDU R，ANNUAR M A，et al. Pharmaco‐
2009，20（2）：272-277. genetics of taxanes：impact of gene polymorphisms of
[12] KIM J W，KIM J H，IM S A，et al. ABCB1，FCGR2A，and drug transporters on pharmacokinetics and toxicity[J].
FCGR3A polymorphisms in patients with HER2-positive Pharmacogenomics，2012，13（16）：1979-1988.
metastatic breast cancer who were treated with first-line [22] CHEN Q Y，LIN W L，YANG J H，et al. Prognostic value
taxane plus trastuzumab chemotherapy[J]. Oncology，2012， of two polymorphisms，rs1045642 and rs1128503，in
83（4）：218-227. ABCB1 following taxane-based chemotherapy：a meta-
[13] 刘新兰，张海霞，赵岳阳，等. ABCB1基因多态性对乳腺 analysis[J]. Asian Pac J Cancer Prev，2021，22（1）：3-10.
癌紫杉类药物化疗疗效的影响[J]. 西安交通大学学报 [23] TAMBURIN S，PARK S B，ALBERTI P，et al. Taxane
（医学版），2016，37（3）：383-387. and epothilone-induced peripheral neurotoxicity：from
LIU X L，ZHANG H X，ZHAO Y Y，et al. Influence of pathogenesis to treatment[J]. J Peripher Nerv Syst，2019，
ABCB1 gene polymorphisms on breast cancer with 24（Suppl. 2）：S40-S51.
paclitaxel-based chemotherapy[J]. J Xi’an Jiaotong Univ [24] YAN M R，FAN X Y，SI H，et al. Association between
Med Sci，2016，37（3）：383-387. gene polymorphism and adverse effects in cancer patients
[14] 李倩，王西勇. ABCB1基因多态性对乳腺癌化疗所致血 receiving docetaxel treatment：a meta-analysis[J]. Cancer
液学毒性的影响观察[J]. 现代科学仪器，2022，39（2）： Chemother Pharmacol，2022，89（2）：173-181.
134-138. （收稿日期：2023-11-03 修回日期：2024-04-24）
LI Q，WANG X Y. Effect of ABCB1 gene polymorphism （编辑：陈 宏）
on hematological toxicity in breast cancer patients receiving

中国药房 2024年第35卷第10期 China Pharmacy 2024 Vol. 35 No. 10 · 1259 ·